US Infection Prevention Products & Services Market

• Publication date: September 2011

US demand to rise 5.1% annually through 2015 US demand for infection prevention products and services is forecast to increase 5.1 percent annually to $21.4 billion in 2015. Stepped up efforts by medical providers to reduce the incidence and mortality of health care-associated infections (HAIs) will underlie growth. Hospitals and other health care establishments are adopting stricter standards involving patient and staff hygiene an...

US demand to rise 5.1% annually through 2015

US demand for infection prevention products and services is forecast to increase 5.1 percent annually to $21.4 billion in 2015. Stepped up efforts by medical providers to reduce the incidence and mortality of health care-associated infections (HAIs) will underlie growth. Hospitals and other health care establishments are adopting stricter standards involving patient and staff hygiene and protection, facility cleaning and disinfection, device and instrument sterilization, and medical waste collection and disposal. Each of these applications will continue to form an attractive, growing niche within the medical supply market. The need for improved infection prevention strategies also extends to the life sciences sector. Stricter FDA standards for product quality control and quality assurance are forcing pharmaceutical and medical device producers to upgrade and expand sterilization and disinfection systems. Additionally, the increasing use of biotechnology-derived microorganisms in investigative and testing procedures is broadening the infection prevention requirements of life science research and medical diagnostic concerns.

Disinfectants, services to be fastest growing segments

Disinfectants consumed by health care and life science facilities will register demand of nearly $2 billion in 2015, up 4.9 percent annually from 2010. Growth will benefit from stepped up pressures on health care facilities to upgrade staff hygiene and facility disinfection practices to defend against HAIs such as MRSA, VRE and C. diff. Disinfectant use in life science facilities will expand as production systems and research and diagnostic investigations become increasingly complex and more vulnerable to microbial contamination. However, as in the case of protective apparel and textiles, multiple supplier availability and limited pricing flexibility will hold down overall growth opportunities for this product group. Compliance with stricter infection prevention and control safeguards by the health care and life science communities will create average or better growth opportunities for medical waste disposal supplies. By contrast, the market for sterilization and other infection prevention equipment will expand at a slow pace due to maturing end-use markets, and retrofitted machinery. Demand for infection prevention services will see above average growth based on the convenience, cost efficiency and regulatory compliance advantages offered to health care and life science facilities. Demand for protective apparel and textiles -- including surgical drapes and gowns, medical and laboratory gloves, face masks and staff apparel, will expand at a below average pace due to trends toward less invasive patient procedures and limited pricing flexibility. The market for safety-enhanced devices, especially IV and urinary catheters and syringes, will grow faster based on stricter OSHA standards aimed at preventing accidental needlesticks and extended health insurance coverage for urinary catheters. Studies indicate that more than half of HAIs and 90 percent of related mortality and nearly all accidental needlesticks could be prevented if hospitals and other health care facilities implemented integrated infection prevention strategies advocated by government and private medical groups.



Study coverage



Details on these and other findings are offered in Infection Prevention Products & Services,which presents historical demand data (2000, 2005, 2010) plus forecasts (2015 and 2020) for infection prevention supplies, equipment and services by type and market. The study also considers market environment factors, evaluates company market share and profiles US industry competitors.

Medical Facility Industry in the United States

TABLE OF CONTENTS

INTRODUCTION xi

I. EXECUTIVE SUMMARY 1

II. MARKET ENVIRONMENT 4

General 4
Economic Factors 5
Demographic Patterns 9
Health Care Trends 12
Health Insurance Coverage 12
Medical Conditions 14
Acute Conditions 15
Chronic Conditions 16
National Health Expenditures 19
Spending Categories 20
Funding Sources 22
Medical Providers 24
Hospitals 27
Physicians & Physicians’ Offices 27
Outpatient Facilities 28
Dentists & Dental Offices 30
Other Medical Establishments 30
Patient Activity 31
Hospital Activity 33
Surgical Procedures 33
Outpatient Activity 33
Diagnostic Tests 34
Life Science Markets 35
Life Science Research & Development Expenditures 36
Pharmaceutical Shipments 37
Medical Supply & Device Shipments 38

III. INFECTION PREVENTION OVERVIEW 39

General 39
Health Care-Associated Infections 40
Urinary Tract Infections 41
Surgical Site Infections 42
Respiratory Infections 43
Blood Infections 44
Skin Infections 44
Other HAIs 45
HAI Costs 46
Regulatory Considerations 46
Historical Demand Patterns 49
US Trade 50
International Markets 52

IV. PRODUCTS & SERVICES 57

General 57
Infection Prevention Overview 59
Infection Prevention Supplies 61
Protective Apparel & Textiles 63
Medical & Laboratory Gloves 65
Examination Gloves 66
Surgical Gloves 69
Laboratory Gloves 73
Surgical Drapes 75
Nonwoven Drapes 77
Plastic & Other Surgical Drapes 79
Applications 80
Surgical Gowns 80
Surgical & Staff Face Masks 83
Other Protective Apparel & Textiles 85
Patient Gowns 86
Staff Apparel 87
All Other Apparel & Textiles 88
Safety-Enhanced Medical Devices 90
Catheters 92
Urinary Catheters 93
IV & Other Safety-Enhanced Catheters 95
Safety-Enhanced Syringes 96
Prefillable Syringes 98
Clinical Syringes 103
Blood Collection Tubes 105
Other Safety-Enhanced Devices 107
Surgical Instruments 107
All Other Safety-Enhanced Devices 108
Sterilization Supplies 110
Sterile Containers 111
Trays 112
Pouches 115
Bags 116
Other Sterile Containers 119
Sterilization Wrap 120
Sterilization Indicators 122
Biological Indicators 123
Chemical Indicators 124
Producers 125
Disinfectants 126
Surface Disinfectants 128
Phenolic Disinfectants 130
Quaternary Ammonium Disinfectants 131
Other Surface Disinfectants 133
Surgical Disinfectants 135
Patient Preparations 136
Surgical Scrubs 137
Instrument Disinfectants 139
Enzyme Detergents 140
Peracetic Acid 142
Ortho-Phthalaldehyde (OPA) 143
Glutaraldehyde 144
Other Instrument Disinfectants 145
Hand Sanitizers 146
Alcohol Preparations 147
Chlorhexidine Gluconate 149
Chloroxylenol 149
Other Hand Sanitizers 150
Medical Waste Disposal Products 150
Medical Waste Disposal Containers 151
Medical Waste Disposal Accessories 154
Infection Prevention Equipment 156
Sterilization Equipment 157
Sterilization Technologies 159
Products & Producers 162
Washing/Disinfecting Equipment 164
Other Infection Prevention Equipment 166
Infectious Waste Receptacles 167
Infectous Waste Processing Units 168
All Other Equipment 168
Infection Prevention Services 170
Medical Waste Disposal Services 171
Contract Sterilization Services 174

V. MARKETS 178

General 178
Health Care Markets 179
Hospitals 183
Market Overview 184
Infection Prevention Demand 185
Outpatient Facilities 187
Ambulatory Surgery Centers 188
Urgent Care Centers 189
Other Outpatient Facilities 190
Physicians’ Offices 191
Dental Offices 193
Nursing Homes 195
Other Health Care Markets 196
Life Science Market 199
Demand by Type 200
Demand by Facility 201
Pharmaceutical Facilities 202
Life Science Research Facilities 203
Medical Supply & Device Facilities 204
Other Facilities 205

VI. INDUSTRY STRUCTURE 207

General 207
Market Share 211
Competitive Strategies 217
Mergers & Acquisitions 218
Licensing & Related Agreements 220
Marketing & Distribution 221
Manufacturing 223
Company Profiles 224
Ahlstrom Corporation 225
Ansell Limited 227
Bard (CR) Incorporated 230
Becton, Dickinson and Company 231
Bemis Company Incorporated 236
Braun (B.) Melsungen AG 238
Caltech Industries, see Clorox
Cantel Medical Corporation 239
Cardinal Health Incorporated 243
CareFusion Corporation 245
Clorox Company 247
Coloplast A/S 249
ConFirm Monitoring Systems, see Cantel Medical
Contec Incorporated 250
Covidien plc 252
Crosstex International, see Cantel Medical
Danaher Corporation 255
Diversey Holdings Incorporated 258
Ecolab Incorporated 260
Getinge AB 265
GOJO Industries Incorporated 267
Hollister Incorporated 268
Johnson & Johnson 269
Kimberly-Clark Corporation 271
Medegen, see CareFusion
Medline Industries Incorporated 274
Microtek Medical, see Ecolab
Minntech, see Cantel Medical
Mölnlycke Health Care AB 278
O’Mara Scientific, see Medline Industries
Pelton & Crane, see Danaher
Purdue Pharma LP 280
Saf-T-Pak, see Cantel Medical
Semperit AG Holding 282
Smiths Group plc 284
STERIS Corporation 285
Sybron Dental Specialties, see Danaher
Terumo Corporation 290
3M Company 291
Unilife Corporation 293
Other Companies Mentioned in the Study 294

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

Summary Table 3

SECTION II -- MARKET ENVIRONMENT

1 Macroeconomic Indicators 8
2 Population by Age Group 11
3 Acute Conditions by Type 16
4 Chronic Conditions by Type 19
5 National Health Expenditures by Category 22
6 National Health Expenditures by Source of Funding 24
7 Medical Providers by Type 26
8 Patient Activity by Type 32
9 Life Science Market Indicators 36

SECTION III -- INFECTION PREVENTION OVERVIEW

1 Number of Health Care-Associated Infections by Type 41
2 Infection Prevention Products & Services Historical Demand
Patterns 50
3 US Trade in Infection Prevention Products 52
4 World Demand for Infection Prevention Products & Services 56

SECTION IV -- PRODUCTS & SERVICES

1 Infection Prevention Product & Service Demand by Category 59
2 Infection Prevention Demand By Application 61
3 Infection Prevention Supplies Demand by Product Group 62
4 Protective Apparel & Textile Demand by Product Group 64
5 Medical & Laboratory Glove Demand by Product Group 66
6 Examination Glove Demand by Type 69
7 Surgical Glove Demand by Type 73
8 Laboratory Glove Demand by Type 75
9 Surgical Drape Demand by Material & Application 77
10 Surgical Gown Demand by Type 83
11 Surgical & Staff Face Mask Demand by Type 85
12 Other Protective Apparel & Textile Demand by Product Group 86
13 Safety-Enhanced Medical Device Demand by Product Group 91
14 Safety-Enhanced Catheter Demand by Type 92
15 Safety-Enhanced Syringe Demand by Type 98
16 Safety-Enhanced Blood Collection Tube Demand 106
17 Other Safety-Enhanced Medical Device Demand by Type 107
18 Sterilization Supplies Demand by Product Group 111
19 Sterile Container Demand by Type 112
20 Sterilization Wrap Demand by Type 122
21 Sterilization Indicator Demand by Type 123
22 Disinfectant Demand by Product Group 128
23 Surface Disinfectant Demand by Type & Classification 130
24 Surgical Disinfectant Demand by Type 135
25 Instrument Disinfectant Demand by Type 140
26 Hand Sanitizer Demand by Type & Formulation 147
27 Medical Waste Disposal Supplies Demand by Group 151
28 Medical Waste Disposal Container Demand 154
29 Medical Waste Disposal Accessories Demand by Type 156
30 Infection Prevention Equipment Demand by Product Group 157
31 Sterilization Equipment Demand by Type 159
32 Washing/Disinfecting Equipment Demand 166
33 Other Infection Prevention Equipment Demand by Type 167
34 Infection Prevention Services Demand by Type 171
35 Medical Waste Disposal Services Demand 174
36 Contract Sterilization Services Demand by Type 177

SECTION V -- MARKETS

1 Infection Prevention Demand by Market 179
2 Health Care Markets Infection Prevention Demand by Facility 182
3 Hospital Infection Prevention Demand by Type 184
4 Outpatient Facility Infection Prevention Demand by Type 188
5 Physicians’ Office Infection Prevention Demand by Type 192
6 Dental Office Infection Prevention Demand by Type 194
7 Nursing Home Infection Prevention Demand by Type 196
8 Other Health Care Markets Infection Prevention Demand
by Type 199
9 Life Science Market Infection Prevention Demand by Type 201
10 Life Science Market Infection Prevention Demand by Facility 202

SECTION VI -- INDUSTRY STRUCTURE

1 Infection Prevention Product Sales by Company, 2010 209
2 Selected Acquisitions & Divestitures 219
3 Selected Cooperative Agreements 221

LIST OF CHARTS

SECTION X -- PRODUCTS & SERVICES

1 Infection Prevention Supplies Demand by Product Group,
2010 63

SECTION XI -- MARKETS
1 Health Care Markets Infection Prevention Demand by Facility,
2010 183

SECTION XII -- INDUSTRY STRUCTURE
1 Infection Prevention Products Market Share, 2010 212

Medical Facility in United States

United States Hospital Admissions, Per `000 Population

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2014
By Business Monitor International
Source: FedStats, Department of Health, World Health Organization (WHO),BMI

• Industries : Medical Facility
• Countries : United States

United States Hospitals, Total

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2014
By Business Monitor International
Source: FedStats, Department of Health, World Health Organization (WHO),BMI

• Industries : Medical Facility
• Countries : United States

United States Doctors, Per `000 Population

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2014
By Business Monitor International
Source: FedStats, Department of Health, World Health Organization (WHO),BMI

• Industries : Medical Facility
• Countries : United States